Harvard Bioscience Inc reports results for the quarter ended in March - Earnings Summary

Harvard Bioscience

06/05/2021 16:15

* Harvard Bioscience Inc  HBIO.OQ  reported quarterly adjusted
earnings of 5 cents​​ per share for the quarter ended in March.
The mean expectation of four analysts for the quarter was
for earnings of 3 cents per share.
* Revenue rose 13.5% to $26.99 million from a year ago​; 
analysts expected $25.73 million.
* Harvard Bioscience Inc's reported EPS for the quarter was a
loss of 2 cents​.
* The mean earnings estimate of analysts had fallen by
about 44.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Harvard Bioscience Inc shares had risen by 24.4% this
quarter and gained 58.3% so far this year.
* The company reported a quarterly loss of $669 thousand.
* Wall Street's median 12-month price target for Harvard
Bioscience Inc is $9.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 6 at 03:15 p.m. GMT. ​All
figures in US Dollars.​